ImmunityBio (IBRX) Enterprise Value (2014 - 2026)
ImmunityBio's (IBRX) quarterly Enterprise Value came in at -$380.0 million in Q1 2026, down 526.63% year-on-year from $89.1 million in Q1 2025, and down 57.07% on a QoQ basis from -$241.9 million in Q4 2025.
ImmunityBio (IBRX) Enterprise Value (2014 - 2026) Analysis & Trends
ImmunityBio (IBRX) has 13 years of Enterprise Value data on file, last reported at -$380.0 million in Q1 2026.
- On a quarterly basis, Enterprise Value fell 526.63% year-over-year to -$380.0 million in Q1 2026; TTM through Mar 2026 was -$380.0 million, a 526.63% decrease from a year earlier, with the FY2025 full-year figure at -$241.9 million, down 62.54% from the prior year.
- Enterprise Value for Q1 2026 stood at -$380.0 million, down from -$241.9 million in the prior quarter.
- Over the last five years, Enterprise Value for IBRX reached as high as -$49.0 million in Q2 2023 and fell as low as -$380.0 million in Q1 2026.
- Historically, Enterprise Value has averaged -$168.0 million across 5 years, with a median of -$152.7 million in 2025.
- Across the five-year window, Enterprise Value surged 65.6% in 2022 and tumbled 526.63% in 2026, its largest moves.
- Year by year, Enterprise Value stood at -$109.7 million in 2022, then tumbled by 141.99% to -$265.4 million in 2023, then soared by 43.92% to -$148.8 million in 2024, then plunged by 62.54% to -$241.9 million in 2025, then sank by 57.07% to -$380.0 million in 2026.
- Per Business Quant data, the three most recent Enterprise Value figures were -$380.0 million in Q1 2026, -$241.9 million in Q4 2025, and -$256.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -61.40 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -4.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -32.26 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | -5.18 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -1.91 Bn |
| 10 | ImmunityBio | 7.60 Bn | 7.22 Bn | 43.97 Mn | -380.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -380.00 Mn |
| Dec 31, 2025 | -241.92 Mn |
| Sep 30, 2025 | -256.90 Mn |
| Jun 30, 2025 | -152.73 Mn |
| Mar 31, 2025 | -60.64 Mn |
| Dec 31, 2024 | -148.84 Mn |
| Sep 30, 2024 | -129.38 Mn |
| Jun 30, 2024 | -216.97 Mn |
| Mar 31, 2024 | -169.47 Mn |
| Dec 31, 2023 | -265.41 Mn |
| Sep 30, 2023 | -188.72 Mn |
| Jun 30, 2023 | -49.02 Mn |
| Mar 31, 2023 | -94.00 Mn |
| Dec 31, 2022 | -109.68 Mn |
| Sep 30, 2022 | -113.44 Mn |
| Jun 30, 2022 | -85.10 Mn |
| Mar 31, 2022 | -194.24 Mn |
| Dec 31, 2021 | -318.86 Mn |
| Sep 30, 2021 | -81.82 Mn |
| Jun 30, 2021 | -104.57 Mn |